Bisindoylmaleimide I enhances osteogenic differentiation

Abstract

The Wnt/β-catenin and bone morphogenetic proteins (BMPs) pathways play important roles in controlling osteogenesis. Using a cell-based kinase inhibitor screening assay, we identified the compound bisindoylmaleimide I (BIM) as a potent agonist of the cytosolic β-catenin accumulation in preosteoblast cells. Through suppressing glycogen synthase kinase 3β enzyme activities, BIM upregulated β-catenin responsive transcription and extended duration of BMP initiated signal. Functional analysis revealed that BIM promoted osteoblast differentiation and bone formation. The treatment of human mesenchymal stem cells with BIM promoted osteoblastogenesis. Our findings provide a new strategy to regulate mesenchymal stem cell differentiation by integration of the cellular signaling pathways.

Keywords

bisindoylmaleimide I / Wnt/β-catenin / glycogen synthase kinase 3β / bone morphogenetic protein / human mesenchymal stem cells (hMSCs) / osteogenesis

References

[1] Behrens, J., von Kries, J.P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. (1996). Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382, 638-642 .10.1038/382638a0
[2] Boyden, L.M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M.A., Wu, D., Insogna, K., and Lifton, R.P. (2002). High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346, 1513-1521 .10.1056/NEJMoa013444
[3] Brunner, E., Peter, O., Schweizer, L., and Basler, K. (1997). pangolin encodes a Lef-1 homologue that acts downstream of Armadillo to transduce the Wingless signal in Drosophila. Nature 385, 829-833 .10.1038/385829a0
[4] Cho, M., Park, S., Gwak, J., Kim, D.E., Yea, S.S., Shin, J.G., and Oh, S. (2008). Bisindoylmaleimide I suppresses adipocyte differentiation through stabilization of intracellular beta-catenin protein. Biochem Biophys Res Commun 367, 195-200 .10.1016/j.bbrc.2007.12.147
[5] Dempsey, E.C., Newton, A.C., Mochly-Rosen, D., Fields, A.P., Reyland, M.E., Insel, P.A., and Messing, R.O. (2000). Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 279, L429-L438 .
[6] Fang, D.X., Hawke, D., Zheng, Y.H., Xia, Y., Meisenhelder, J., Nika, H., Mills, G.B., Kobayashi, R., Hunter, T., and Lu, Z.M. (2007). Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem 282, 11221-11229 .10.1074/jbc.M611871200
[7] Fuentealba, L.C., Eivers, E., Ikeda, A., Hurtado, C., Kuroda, H., Pera, E.M., and De Robertis, E.M. (2007). Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131, 980-993 .10.1016/j.cell.2007.09.027
[8] Fujita, K., and Janz, S. (2007). Attenuation of WNT signaling by DKK-1 and-2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. Mol Cancer 6, 71.10.1186/1476-4598-6-71
[9] Gaur, T., Lengner, C.J., Hovhannisyan, H., Bhat, R.A., Bodine, P.V., Komm, B.S., Javed, A., van Wijnen, A.J., Stein, J.L., Stein, G.S., . (2005). Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280, 33132-33140 .10.1074/jbc.M500608200
[10] Glass, D.A. 2nd, Bialek, P., Ahn, J.D., Starbuck, M., Patel, M.S., Clevers, H., Taketo, M.M., Long, F., McMahon, A.P., Lang, R.A., . (2005). Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8, 751-764 .10.1016/j.devcel.2005.02.017
[11] Gong, Y., Slee, R.B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A.M., Wang, H., Cundy, T., Glorieux, F.H., Lev, D., ., and the Osteoporosis-Pseudoglioma Syndrome Collaborative Group. (2001). LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513-523 .10.1016/S0092-8674(01)00571-2
[12] He, X.C., Yin, T., Grindley, J.C., Tian, Q., Sato, T., Tao, W.A., Dirisina, R., Porter-Westpfahl, K.S., Hembree, M., Johnson, T., . (2007). PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet 39, 189-198 .10.1038/ng1928
[13] Hers, I., Tavaré, J.M., and Denton, R.M. (1999). The protein kinase C inhibitors bisindolylmaleimide I (GF 109203x) and IX (Ro 31-8220) are potent inhibitors of glycogen synthase kinase-3 activity. FEBS Lett 460, 433-436 .10.1016/S0014-5793(99)01389-7
[14] Hino, S., Tanji, C., Nakayama, K.I., and Kikuchi, A. (2005). Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination. Mol Cell Biol 25, 9063-9072. 10.1128/MCB.25.20.9063-9072.2005
[15] Holmen, S.L., Zylstra, C.R., Mukherjee, A., Sigler, R.E., Faugere, M.C., Bouxsein, M.L., Deng, L., Clemens, T.L., and Williams, B.O. (2005). Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem 280, 21162-21168 .10.1074/jbc.M501900200
[16] Honda, T., Yamamoto, H., Ishii, A., and Inui, M. (2010). PDZRN3 negatively regulates BMP-2-induced osteoblast differentiation through inhibition of Wnt signaling. Mol Biol Cell 21, 3269-3277 .10.1091/mbc.E10-02-0117
[17] Hsu, S.C., Galceran, J., and Grosschedl, R. (1998). Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin. Mol Cell Biol 18, 4807-4818 .
[18] Korchynskyi, O., and ten Dijke, P. (2002). Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277, 4883-4891 .10.1074/jbc.M111023200
[19] Korinek, V., Barker, N., Morin, P.J., vanWichen, D., deWeger, R., Kinzler, K.W., Vogelstein, B., and Clevers, H. (1997). Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC(-/-) colon carcinoma. Science 275, 1784-1787 .10.1126/science.275.5307.1784
[20] Kramer, I., Halleux, C., Keller, H., Pegurri, M., Gooi, J.H., Weber, P.B., Feng, J.Q., Bonewald, L.F., and Kneissel, M. (2010). Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol 30, 3071-3085 .10.1128/MCB.01428-09
[21] Lian, J.B., Stein, G.S., Javed, A., van Wijnen, A.J., Stein, J.L., Montecino, M., Hassan, M.Q., Gaur, T., Lengner, C.J., and Young, D.W. (2006). Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord 7, 1-16 .10.1007/s11154-006-9001-5
[22] Little, R.D., Carulli, J.P., Del Mastro, R.G., Dupuis, J., Osborne, M., Folz, C., Manning, S.P., Swain, P.M., Zhao, S.C., Eustace, B., . (2002). A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70, 11-19 .10.1086/338450
[23] Nie, J., Wang, H., He, F., and Huang, H. (2010). Nusap1 is essential for neural crest cell migration in zebrafish. Protein Cell 1, 259-266 .10.1007/s13238-010-0036-8
[24] Pajak, B., Orzechowska, S., Gajkowska, B., and Orzechowski, A. (2008). Bisindolylmaleimides in anti-cancer therapy- more than PKC inhibitors. Adv Med Sci 53, 21-31 .10.2478/v10039-008-0028-6
[25] Qiang, Y.W., Barlogie, B., Rudikoff, S., and Shaughnessy, J.D. Jr. (2008). Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma. Bone 42, 669-680 .10.1016/j.bone.2007.12.006
[26] Rawadi, G., Vayssière, B., Dunn, F., Baron, R., and Roman-Roman, S. (2003). BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18, 1842-1853 .10.1359/jbmr.2003.18.10.1842
[27] Rosen, C.J. (2003). The cellular and clinical parameters of anabolic therapy for osteoporosis. Crit Rev Eukaryot Gene Expr 13, 25-38 .10.1615/CritRevEukaryotGeneExpr.v13.i1.30
[28] Spencer, G.J., Utting, J.C., Etheridge, S.L., Arnett, T.R., and Genever, P.G. (2006). Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro. J Cell Sci 119, 1283-1296 .10.1242/jcs.02883
[29] Takada, I., Kouzmenko, A.P., and Kato, S. (2009). Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 5, 442-447 .10.1038/nrrheum.2009.137
[30] Tang, N., Song, W.X., Luo, J., Luo, X., Chen, J., Sharff, K.A., Bi, Y., He, B.C., Huang, J.Y., Zhu, G.H., . (2009). BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. J Cell Mol Med 13, 2448-2464 .10.1111/j.1582-4934.2008.00569.x
[31] Taurin, S., Sandbo, N., Qin, Y.M., Browning, D., and Dulin, N.O. (2006). Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase. J Biol Chem 281, 9971-9976 .10.1074/jbc.M508778200
[32] ten Dijke, P. (2006). Bone morphogenetic protein signal transduction in bone. Curr Med Res Opin 22, S7-S11 .10.1185/030079906X80576
[33] van Dinther, M., Visser, N., de Gorter, D.J., Doorn, J., Goumans, M.J., de Boer, J., and ten Dijke, P. (2010). ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation. J Bone Miner Res 25, 1208-1215 .
[34] Vukicevic, S., and Grgurevic, L. (2009). BMP-6 and mesenchymal stem cell differentiation. Cytokine Growth Factor Rev 20, 441-448 .10.1016/j.cytogfr.2009.10.020
[35] Zhang, B., and Ma, J.X. (2010). Wnt pathway antagonists and angiogenesis. Protein Cell 1, 898-906 .10.1007/s13238-010-0112-0
[36] Zhang, L., Gao, X., Wen, J., Ning, Y., and Chen, Y.G. (2006). Dapper 1 antagonizes Wnt signaling by promoting dishevelled degradation. J Biol Chem 281, 8607-8612 .10.1074/jbc.M600274200
[37] Zhang, L., Zhou, F., van Laar, T., Zhang, J., van Dam, H., and Ten Dijke, P. (2011). Fas-associated factor 1 antagonizes Wnt signaling by promoting beta-catenin degradation. Mol Biol Cell 22, 1617-1624 .10.1091/mbc.E10-12-0985
[38] Zhao, A.Z., and Su, D. (2011). An “endocrine function of” bone to pick: starting with males. Protein Cell 2, 171-172 .10.1007/s13238-011-1035-0
[39] Zhou, F., van Laar, T., Huang, H., and Zhang, L. (2011a). APP and APLP1 are degraded through autophagy in response to proteasome inhibition in neuronal cells. Protein Cell 2, 377-383 .10.1007/s13238-011-1047-9
[40] Zhou, F., Zhang, L., Gong, K., Lu, G., Sheng, B., Wang, A., Zhao, N., Zhang, X., and Gong, Y. (2008a). LEF-1 activates the transcription of E2F1. Biochem Biophys Res Commun 365, 149-153 .10.1016/j.bbrc.2007.10.138
[41] Zhou, F., Zhang, L., van Laar, T., van Dam, H., and Ten Dijke, P. (2011b). GSK3 beta inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb. Mol Biol Cell 22, 3533-3540 .10.1091/mbc.E11-06-0483
[42] Zhou, F., Zhang, L., Wang, A., Song, B., Gong, K., Zhang, L., Hu, M., Zhang, X., Zhao, N., and Gong, Y. (2008b). The association of GSK3 beta with E2F1 facilitates nerve growth factor-induced neural cell differentiation. J Biol Chem 283, 14506-14515 .10.1074/jbc.M706136200